Table 2.
Multivariate analysis of factors associated with transplant outcomes
| HR | 95 % CI | P value | |
|---|---|---|---|
| Primary graft failure | |||
| DSA | |||
| MFI ≥ 10,000 | 1 | ||
| 2000 ≤ MFI < 10,000 | 0.940 | 0.284–3.177 | 0.919 |
| MFI < 2000 | 0.187 | 0.048–0.730 | 0.016 |
| OS | |||
| Disease status | 2.839 | 1.702–4.736 | 0.000 |
| Primary graft failure | |||
| GR | 1 | ||
| PGF | 0.271 | 0.074–1.000 | 0.050 |
| No primary graft failure | 0.068 | 0.020–0.229 | 0.000 |
| DFS | |||
| Disease status | 3.593 | 2.212–5.836 | 0.000 |
| PGF | 3.125 | 1.564–6.244 | 0.000 |
| GR | 1 | ||
| PGF | 0.284 | 0.077–1.044 | 0.058 |
| No primary graft failure | 0.084 | 0.025–0.279 | 0.000 |
| Relapse | |||
| Disease status | 9.906 | 4.099–23.940 | 0.000 |
| TRM | |||
| PGF | |||
| GR | 1 | ||
| PGF | 0.209 | 0.056–0.790 | 0.021 |
| No primary graft failure | 0.031 | 0.0009–0.107 | 0.000 |
| ANC | |||
| CD34 | 1.370 | 1.106–1.697 | 0.004 |
| PLT | |||
| CD34 | 1.483 | 1.187–1.852 | 0.001 |
| DSA | |||
| MFI ≥ 10,000 | 1 | ||
| 2000 ≤ MFI < 10,000 | 3.074 | 1.137–8.311 | 0.027 |
| MFI < 2000 | 3.301 | 1.358–8.022 | 0.008 |
Abbreviations: HR hazard ratio, CI confidence interval, DSAs donor-specific antibodies, MFI median fluorescence intensity, OS overall survival, GR graft rejection, PGF poor graft function, DFS disease-free survival, TRM transplant-related mortality, ANC absolute neutrophil count, PLT platelet